Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Gardasil
Active Ingredients: Human Papillomavirus (HPV) 11 L1 Protein 80µg/mL
Human Papillomavirus (HPV) 16 L1 Protein 80µg/mL
Human Papillomavirus (HPV) 18 L1 Protein 40µg/mL
Human Papillomavirus (HPV) 6 L1 Protein 40µg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck & Co Inc, West Point, Pennsylvania, United States of America
Product: Octaplas (Blood Group A)
Active Ingredient: Plasma protein fraction 9-14g
Dosage Form: Solution for injection
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturer: Octapharma Pharmazeutika Productionsges, Vienna, Austria
Product: Octaplas (Blood Group B)
Active Ingredient: Plasma protein fraction 9-14g
Dosage Form: Solution for injection
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturer: Octapharma Pharmazeutika Productionsges, Vienna, Austria
Product: Octaplas (Blood Group AB)
Active Ingredient: Plasma protein fraction 9-14g
Dosage Form: Solution for injection
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturer: Octapharma Pharmazeutika Productionsges, Vienna, Austria
Product: Octaplas (Blood Group O)
Active Ingredient: Plasma protein fraction 9-14g
Dosage Form: Solution for injection
New Zealand Sponsor: Octapharma New Zealand Limited
Manufacturer: Octapharma Pharmazeutika Productionsges, Vienna, Austria
Product: Prexige
Active Ingredient: Lumiracoxib 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Redoxon Double Action
Active Ingredients: Ascorbic acid 1,000mg
Zinc citrate 32mg equivalent to zinc 10mg
Dosage Form: Effervescent tablet
New Zealand Sponsor: Bayer (NZ) Limited
Manufacturer: Roche Products Pty Limited, Dee Why, New South Wales, Australia
Product: Riamet
Active Ingredients: Artemether 20mg
Lumefantrine 120mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited Pharmaceutical Sector
Manufacturer: Novartis Pharma Beijing, Nanguan, Chengguan Township, Changping County, Beijing, China
Dated this 13th day of July 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go4894